Bank of America
HRTX icon

Bank of America’s Heron Therapeutics HRTX Stock Holding History

Bank of America’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$129K Buy
160,979
+26,534
+20% +$30.7K ﹤0.01% 5481
2025
Q4 		$175K Sell
134,445
-597,628
-82% -$738K ﹤0.01% 5402
2025
Q3 		$922K Sell
732,073
-343,196
-32% -$544K ﹤0.01% 5383
2025
Q2 		$2.23M Buy
1,075,269
+107,228
+11% +$219K ﹤0.01% 4675
2025
Q1 		$2.13M Sell
968,041
-78,749
-8% -$153K ﹤0.01% 4625
2024
Q4 		$1.6M Buy
1,046,790
+90,862
+10% +$147K ﹤0.01% 4636
2024
Q3 		$1.9M Buy
955,928
+521,629
+120% +$1.25M ﹤0.01% 4602
2024
Q2 		$1.52M Buy
434,299
+199,257
+85% +$612K ﹤0.01% 4627
2024
Q1 		$651K Buy
235,042
+48,564
+26% +$122K ﹤0.01% 5191
2023
Q4 		$317K Buy
186,478
+94,694
+103% +$104K ﹤0.01% 5799
2023
Q3 		$94.5K Buy
91,784
+31,195
+51% +$44.4K ﹤0.01% 6271
2023
Q2 		$70.3K Sell
60,589
-45,418
-43% -$81K ﹤0.01% 6342
2023
Q1 		$160K Sell
106,007
-9,589
-8% -$24K ﹤0.01% 6035
2022
Q4 		$289K Sell
115,596
-451,260
-80% -$1.45M ﹤0.01% 5716
2022
Q3 		$2.39M Sell
566,856
-160,081
-22% -$626K ﹤0.01% 4099
2022
Q2 		$2.03M Sell
726,937
-879,907
-55% -$3.53M ﹤0.01% 4291
2022
Q1 		$9.19M Buy
1,606,844
+1,261,600
+365% +$9.23M ﹤0.01% 2942
2021
Q4 		$3.15M Buy
345,244
+238,708
+224% +$2.44M ﹤0.01% 4110
2021
Q3 		$1.14M Sell
106,536
-16,533
-13% -$201K ﹤0.01% 4942
2021
Q2 		$1.91M Sell
123,069
-166,836
-58% -$2.65M ﹤0.01% 4364
2021
Q1 		$4.7M Buy
289,905
+88,239
+44% +$1.57M ﹤0.01% 3459
2020
Q4 		$4.27M Sell
201,666
-24,524
-11% -$426K ﹤0.01% 3276
2020
Q3 		$3.35M Buy
226,190
+12,681
+6% +$198K ﹤0.01% 3277
2020
Q2 		$3.14M Sell
213,509
-148,148
-41% -$2.43M ﹤0.01% 3268
2020
Q1 		$4.25M Buy
361,657
+20,011
+6% +$376K ﹤0.01% 2811
2019
Q4 		$8.03M Buy
341,646
+77,303
+29% +$1.71M ﹤0.01% 2778
2019
Q3 		$4.89M Sell
264,343
-105,829
-29% -$1.95M ﹤0.01% 3228
2019
Q2 		$6.88M Sell
370,172
-78,962
-18% -$1.58M ﹤0.01% 2919
2019
Q1 		$11M Buy
449,134
+231,839
+107% +$6.07M ﹤0.01% 2388
2018
Q4 		$5.64M Sell
217,295
-32,324
-13% -$889K ﹤0.01% 2864
2018
Q3 		$7.9M Sell
249,619
-6,061
-2% -$226K ﹤0.01% 2725
2018
Q2 		$9.93M Buy
255,680
+42,756
+20% +$1.36M ﹤0.01% 2475
2018
Q1 		$5.88M Buy
212,924
+158,710
+293% +$3.6M ﹤0.01% 2924
2017
Q4 		$982K Sell
54,214
-3,421
-6% -$55.8K ﹤0.01% 4502
2017
Q3 		$930K Sell
57,635
-18,730
-25% -$294K ﹤0.01% 4565
2017
Q2 		$1.06M Buy
76,365
+22,036
+41% +$319K ﹤0.01% 4396
2017
Q1 		$815K Buy
54,329
+2,834
+6% +$39.2K ﹤0.01% 4559
2016
Q4 		$675K Buy
51,495
+6,848
+15% +$107K ﹤0.01% 4616
2016
Q3 		$769K Buy
44,647
+3,513
+9% +$65.2K ﹤0.01% 4337
2016
Q2 		$742K Sell
41,134
-5,165
-11% -$101K ﹤0.01% 4394
2016
Q1 		$879K Buy
46,299
+7,370
+19% +$145K ﹤0.01% 4192
2015
Q4 		$1.04M Buy
38,929
+30,190
+345% +$807K ﹤0.01% 4351
2015
Q3 		$214K Sell
8,739
-7,969
-48% -$266K ﹤0.01% 5299
2015
Q2 		$521K Buy
16,708
+16,639
+24,114% +$313K ﹤0.01% 4667
2015
Q1 		$1K Sell
69
-1,731
-96% -$19.5K ﹤0.01% 6811
2014
Q4 		$18K Sell
1,800
-3,360
-65% -$27.4K ﹤0.01% 6837
2014
Q3 		$43K Sell
5,160
-1,211
-19% -$11.3K ﹤0.01% 6601
2014
Q2 		$78K Buy
+6,371
New +$76.1K ﹤0.01% 6326

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Bank of America's HRTX Position: Q1 2026 in Review

Bank of America increased its Heron Therapeutics (HRTX) stake by 20% in Q1 2026, buying an estimated $30.7K and bringing the position to 160,979 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #5481.

Bank of America first reported a position in HRTX in Q2 2014 and has held it in 48 quarters since. The position peaked at $11M in Q1 2019. 167 funds tracked by Wall St. Rank hold HRTX as of Q1 2026.

  • Bank of America held 160,979 shares of Heron Therapeutics worth $129K as of Q1 2026.
  • Bank of America bought 26,534 Heron Therapeutics shares in Q1 2026, an estimated $30.7K.
  • Heron Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5481 holding.
  • Bank of America first reported a position in Heron Therapeutics in Q2 2014 and has held it in 48 quarters since.
  • Bank of America's Heron Therapeutics position peaked at $11M in Q1 2019.
  • 167 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.